Distribuzione geografica
Continente #
EU - Europa 2124
NA - Nord America 1927
AS - Asia 650
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 4
Totale 4726
Nazione #
US - Stati Uniti d'America 1916
IE - Irlanda 820
CN - Cina 513
UA - Ucraina 446
SE - Svezia 332
IT - Italia 194
FR - Francia 87
FI - Finlandia 80
TR - Turchia 76
DE - Germania 68
IN - India 51
BE - Belgio 39
GB - Regno Unito 30
CA - Canada 11
RO - Romania 9
TN - Tunisia 8
RU - Federazione Russa 7
EU - Europa 6
SC - Seychelles 6
KR - Corea 4
AT - Austria 3
CL - Cile 3
CZ - Repubblica Ceca 3
ID - Indonesia 3
ES - Italia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
GR - Grecia 1
JP - Giappone 1
NL - Olanda 1
PT - Portogallo 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 4726
Città #
Dublin 820
Chandler 453
Jacksonville 310
Nyköping 235
Dearborn 221
Nanjing 153
Princeton 77
Wilmington 74
Beijing 63
Ann Arbor 61
San Mateo 51
Foggia 49
Nanchang 46
Brussels 39
Shenyang 36
Helsinki 32
Des Moines 30
Hebei 28
Tianjin 26
Woodbridge 26
Kunming 23
Jinan 19
Hangzhou 18
Changsha 17
Jiaxing 15
Ningbo 13
Zhengzhou 12
Los Angeles 10
Bari 8
Boardman 8
Milan 8
Orange 8
Rome 8
Hilden 7
Lanzhou 7
New York 7
Wuhan 7
Auburn Hills 6
Guangzhou 6
Naples 6
Redwood City 6
Stevenage 6
Washington 6
Chengdu 5
Dallas 5
Frankfurt am Main 5
Falls Church 4
Toronto 4
Augusta 3
Bussolengo 3
Changchun 3
Chicago 3
Fuzhou 3
Kocaeli 3
London 3
Molfetta 3
Moscow 3
Norwalk 3
Paris 3
Andover 2
Borås 2
Cedar Knolls 2
Centro 2
Chongqing 2
Chuncheon 2
Delta 2
Ginosa 2
Hanover 2
Hefei 2
Lecce 2
Montréal 2
Ottawa 2
Pescara 2
Philadelphia 2
Saint Petersburg 2
Salzburg 2
Aberdeen 1
Amsterdam 1
Baltimore 1
Belgrade 1
Benatky nad Jizerou 1
Brescia 1
Buffalo 1
Capaccio 1
Cincinnati 1
Cisano Bergamasco 1
Clearwater 1
Como 1
Desenzano del Garda 1
Gainesville 1
Geislingen an der Steige 1
Haddon Heights 1
Haikou 1
Hangyang 1
Harlow 1
Las Vegas 1
Leawood 1
Lisbon 1
Mcallen 1
Messina 1
Totale 3175
Nome #
Antidepressant drugs for beta amyloid-induced depression: A new standpoint? 121
Social memory impairment in a triple-transgenic mouse model of Alzhemer's disease is accompained by monoaminergic alterations 118
N-3 PUFA diet enrichment prevents amyloid beta-induced depressive-like phenotype 107
The cannabinoid agonist WIN55212-2 normalizes levodopa-induced volume transmission unbalances across the two brain hemispheres of dyskinetic rats 103
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis 101
Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? 101
Cognitive deficits are paralleled by increased emotionality and altered glutamatergic and monoaminergic neurotransmission in rats perinatally exposed to a moderate dose of delta9-tetrahydrocannabinol 96
Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats 92
Mice lacking fatty acid amide hydrolase (FAAH-/-) showed increased serotonergic neurotransmission and reduced emotional reactivity 92
Influence of nitric oxide on cortical dopaminergic system in an animal model of Alzheimer’s disease: an in vivo study 92
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: Role of CB(1) and TRPV1 receptors 87
Cannabinoids normalize neurochemical unbalances across the two hemispheres of dyskinetic rats 86
Chlorella sorokiniana extract improves short-term memory in rats 79
Chronic psychosocial stress impairs bone homeostasis: A study in the social isolation reared rat 79
Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion 77
Canakinumab in recessive dystrophic epidermolysis bullosa: a novel unexpected weapon for non-healing wounds? 76
Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1 76
Striatal 6-Ohda Lesion In Mice: Investigating Early Neurochemical Changes Underlying Parkinson's Disease 73
Neurochemical differences in two rat strains exposed to social isolation rearing 73
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats 73
Celecoxib Prevents Cognitive Impairment and Neuroinflammation in Soluble Amyloid β-treated Rats 73
Chronic nandrolone administration induces dysfunction of the reward pathway in rats. 72
Extraction, Characterization and In Vivo Neuromodulatory Activity of Phytosterols from Microalga Dunaliella Tertiolecta. 71
Carvacrol: from ancient flavoring to neuromodulatory agent. 71
The NADPH oxidase NOX2 as a novel biomarker for suicidality: Evidence from human post mortem brain samples 71
Visceral fat dysfunctions in the rat social isolation model of psychosis 71
Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2 71
Lifelong Nutritional Omega-3 Deficiency Evokes Depressive-Like State Through Soluble Beta Amyloid 70
Early life and oxidative stress in psychiatric disorders: what can we learn from animal models? 69
Ketamine administration induces early and persistent neurochemical imbalance and altered NADPH oxidase in mice 69
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function 68
The cannabinoid agonist WIN55212,2 decreases L-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats 67
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice 67
Effects of n-3 PUFA enriched and n-3 PUFA deficient diets in naïve and Aβ-treated female rats 67
Estrous cycle affects the neurochemical and neurobehavioral profile of carvacrol-treated female rats 66
Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy 66
Effects of anabolic-androgens on brain reward function 65
Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2 65
Special Issue "Potential Neuromodulatory Profile of Phytocompounds in Brain Disorders" 65
Improvement of renal function in epidermolysis bullosa patients after gluten free diet: two cases 64
The Visible Burrow System: A behavioral paradigm to assess sociability and social withdrawal in BTBR and C57BL/6J mice strains 64
Solubile beta amyloid- induced alterations: neurochemical, behavioural and biochemical evidence in rats 63
Depressive-like phenotype evoked by lifelong nutritional omega-3 deficiency in female rats: Crosstalk among kynurenine, Toll-like receptors and amyloid beta oligomers 60
A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats 59
Early Loss of Blood-Brain Barrier Integrity Precedes NOX2 Elevation in the Prefrontal Cortex of an Animal Model of Psychosis 59
Sub-chronic celecoxib prevents soluble beta amyloid-induced depressive-like behaviour in rats 56
Early celastrol administration prevents ketamine-induced psychotic-like behavioral dysfunctions, oxidative stress and IL-10 reduction in the cerebellum of adult mice 56
Neuroendocrine profile in a rat model of psychosocial stress: relation to oxidative stress. 55
Modulatory Activity of Soluble Beta Amyloid on Hpa Axis Function in Rats. 55
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 55
Nonmotor symptoms in Parkinson's disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model 55
Prevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epidermolysis bullosa 54
Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats 53
Postnatal Antioxidant and Anti-inflammatory Treatments Prevent Early Ketamine-Induced Cortical Dysfunctions in Adult Mice 52
N-3 PUFA Prevent Oxidative Stress in a Rat Model of Beta-Amyloid-Induced Toxicity 51
Neurochemical consequence of steroid abuse: stanozolol-induced monoaminergic changes 50
Emerging role of amyloid beta in stress response: Implication for depression and diabetes 49
Increased iNOS and nitrosative stress in dopaminergic neurons of MDMA-exposed rats 48
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice 48
Precision Medicine in Alzheimer’s Disease: Investigating Comorbid Common Biological Substrates in the Rat Model of Amyloid Beta-Induced Toxicity 48
Maternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty Acids 47
Sex-tailored pharmacology and COVID-19: next steps towards appropriateness and health equity 47
Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target 43
Social isolation triggers oxidative status and impairs systemic and hepatic insulin sensitivity in normoglycemic rats 39
SARS-CoV-2 Gamma and Delta Variants of Concern Might Undermine Neutralizing Activity Generated in Response to BNT162b2 mRNA Vaccination 38
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 38
Ketamine administration in early postnatal life as a tool for mimicking Autism Spectrum Disorders core symptoms 37
Monoaminergic system modulation in depression and Alzheimer's disease: A new standpoint? 35
Sublingual AKBA Exerts Antidepressant Effects in the Aβ-Treated Mouse Model 34
The therapeutic potential of celastrol in central nervous system disorders: Highlights from in vitro and in vivo approaches 29
Palmitoylethanolamide counteracts brain fog improving depressive-like behaviour in obese mice: Possible role of synaptic plasticity and neurogenesis 26
Glucoraphanin Triggers Rapid Antidepressant Responses in a Rat Model of Beta Amyloid-Induced Depressive-like Behaviour 25
Social isolation from early life induces anxiety-like behaviors in adult rats: Relation to neuroendocrine and neurochemical dysfunctions 17
Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice 15
Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice 14
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials 4
Totale 4991
Categoria #
all - tutte 14138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14138

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20188 0000 00 00 0008
2018/2019458 217422 11167 9219 6152065
2019/20201072 1851416710 125128 18519 98109410
2020/2021591 7289610 8215 9420 1008725
2021/2022480 56111611 2213 1738 687616136
2022/20231968 1569770123 89171 21194 98114520
Totale 4991